Related Experiment Video

Updated: Aug 22, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae

Paul F Riska1, Andrei Kutlin, Patrick Ajiboye

  • 1Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, USA. riska@att.net

Antimicrobial Agents and Chemotherapy
|August 26, 2004
PubMed

Insights

Investigating azithromycin resistance in Chlamydia pneumoniae, this study found no genetic basis for increased MICs in clinical isolates. In vitro attempts to induce macrolide resistance were also unsuccessful, highlighting a gap in understanding C. pneumoniae resistance mechanisms.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Chlamydia pneumoniae is a significant respiratory pathogen.
  • Macrolide antibiotics, like azithromycin, are commonly used for C. pneumoniae infections.
  • Emergence of antibiotic resistance is a growing concern in treating bacterial infections.

Purpose of the Study:

  • To investigate the genetic basis for increased azithromycin minimum inhibitory concentrations (MICs) in clinical Chlamydia pneumoniae isolates.
  • To determine if macrolide resistance can be induced in vitro in C. pneumoniae.

Main Methods:

  • Analysis of three clinical Chlamydia pneumoniae isolates exhibiting increased azithromycin MICs post-treatment.
  • Genetic investigation for known macrolide resistance mechanisms.
  • In vitro attempts to induce antibiotic resistance through serial passage or other methods.

Main Results:

  • No specific genetic mechanism for the observed increase in azithromycin MICs was identified in the clinical C. pneumoniae isolates.
  • In vitro experiments failed to induce macrolide resistance in Chlamydia pneumoniae.

Conclusions:

  • The study did not identify a genetic cause for the elevated azithromycin MICs in the investigated C. pneumoniae isolates.
  • Current in vitro methods were insufficient to generate macrolide-resistant C. pneumoniae strains, suggesting complex resistance pathways or limitations in experimental models.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...